Smith Salley & Associates increased its position in DuPont Co. (NYSE:DD) by 3.7% during the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 68,752 shares of the company’s stock after buying an additional 2,483 shares during the period. Smith Salley & Associates’ holdings in DuPont were worth $4,455,000 at the end of the most recent reporting period.
Several other institutional investors also recently modified their holdings of DD. Integrated Investment Consultants LLC increased its stake in DuPont by 10.3% in the second quarter. Integrated Investment Consultants LLC now owns 2,050 shares of the company’s stock worth $133,000 after buying an additional 191 shares during the last quarter. Signaturefd LLC increased its stake in DuPont by 30.4% in the second quarter. Signaturefd LLC now owns 2,973 shares of the company’s stock worth $193,000 after buying an additional 693 shares during the last quarter. CrestPoint Capital Management LLC acquired a new stake in DuPont during the second quarter worth about $201,000. Ariel Capital Advisors LLC acquired a new stake in DuPont during the second quarter worth about $201,000. Finally, Nicolet Bankshares Inc. acquired a new stake in DuPont during the second quarter worth about $209,000. Hedge funds and other institutional investors own 70.30% of the company’s stock.
DuPont Co. (NYSE:DD) traded down 0.42% during midday trading on Monday, reaching $68.74. 852,766 shares of the company were exchanged. DuPont Co. has a 52-week low of $50.71 and a 52-week high of $75.72. The company has a market capitalization of $60.10 billion, a price-to-earnings ratio of 27.34 and a beta of 1.78. The company has a 50 day moving average of $68.20 and a 200-day moving average of $66.85.
DuPont (NYSE:DD) last released its quarterly earnings results on Tuesday, July 26th. The company reported $1.24 EPS for the quarter, topping the Thomson Reuters’ consensus estimate of $1.10 by $0.14. DuPont had a return on equity of 24.59% and a net margin of 9.01%. The business earned $7.10 billion during the quarter, compared to analysts’ expectations of $7.01 billion. During the same quarter in the prior year, the business earned $1.18 earnings per share. The company’s quarterly revenue was down .8% compared to the same quarter last year. On average, equities research analysts anticipate that DuPont Co. will post $3.19 earnings per share for the current fiscal year.
A number of equities research analysts recently issued reports on the stock. Vetr downgraded shares of DuPont from a “buy” rating to a “hold” rating and set a $69.68 price target on the stock. in a research note on Monday, June 20th. Barclays PLC reissued a “neutral” rating on shares of DuPont in a research note on Thursday, July 28th. Citigroup Inc. raised shares of DuPont from a “neutral” rating to a “buy” rating and increased their target price for the company from $72.00 to $76.00 in a research note on Monday, October 3rd. Deutsche Bank AG raised their price target on shares of DuPont from $55.00 to $56.00 and gave the stock a “sell” rating in a research note on Friday, August 12th. Finally, TheStreet downgraded shares of DuPont from a “buy” rating to a “hold” rating in a research note on Tuesday, July 26th. Four investment analysts have rated the stock with a sell rating, nine have given a hold rating and six have given a buy rating to the stock. DuPont presently has a consensus rating of “Hold” and a consensus price target of $70.73.
In other DuPont news, insider James C. Jr. Collins sold 50,316 shares of the stock in a transaction on Wednesday, August 24th. The stock was sold at an average price of $70.30, for a total value of $3,537,214.80. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, EVP Christopher Marc Doyle sold 5,422 shares of the stock in a transaction on Friday, August 26th. The stock was sold at an average price of $69.53, for a total value of $376,991.66. The disclosure for this sale can be found here. Insiders own 0.31% of the company’s stock.
E. I. du Pont de Nemours and Company (DuPont) is a science and technology-based company. The Company consists of over 10 businesses aggregated into six segments: Agriculture, Electronics & Communications, Industrial Biosciences, Nutrition & Health, Performance Materials and Safety & Protection. Its products include corn hybrids and soybean varieties, herbicides, fungicides and insecticides in Agriculture segment; photopolymers and electronic materials in Electronics & Communications segment; enzymes and bio-based materials in Industrial Biosciences segment; cultures, emulsifiers, texturants, natural sweeteners and soy-based food ingredients in Nutrition & Health segment; engineering polymers, packaging and industrial polymers, films and elastomers in Performance Materials segment, and nonwovens, aramids and solid surfaces in Safety & Protection segment.
Want to see what other hedge funds are holding DD? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for DuPont Co. (NYSE:DD).
Receive News & Ratings for DuPont Co. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DuPont Co. and related companies with MarketBeat.com's FREE daily email newsletter.